Liang Wu

Dr. Liang Wu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2016 in Molecules
Verified
Journal Article
Open access
PDF file
HPHanqing Pang
Hanqing Pang
LWLiang Wu
Liang Wu
YTYu-Ping Tang
Yu-Ping Tang
GZGuishneg Zhou
Guishneg Zhou
CQCheng Qu
Cheng Qu
JDJin'ao Duan
Jin'ao Duan
Radix Salviae miltiorrhizae et Rhizoma, known as Danshen in China, is one of the most popular traditional Chinese medicines. Recently, there has been increasing scientific attention on Danshen for its remarkable bioactivities, such as promoting blood circulation, removing blood stasis, and clearing away heat. This review summarized the advances in chemical analysis of Danshen and its preparations since 2009. Representative established methods were reviewed, including spectroscopy, thin layer chromatography, gas chromatography, liquid chromatography (LC), liquid chromatography-mass spectrometry (LC-MS), capillary electrophoresis, electrochemistry, and bioanalysis. Especially the analysis of polysaccharides in Danshen was discussed for the first time. Some proposals were also put forward to benefit quality control of Danshen.


27 November 2017 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
LWLiang Wu
Liang Wu
YTYu-Ping Tang
Yu-Ping Tang
CSChenxiao Shan
Chenxiao Shan
CCChuan Chai
Chuan Chai
ZZZhu Zhou
Zhu Zhou
Ren Xiang TanRen Xiang Tan
Ren Xiang Tan

1 October 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
LWLiang Wu
Liang Wu
AKAn Kang
An Kang
CSChenxiao Shan
Chenxiao Shan
CCChuan Chai
Chuan Chai
ZZZhu Zhou
Zhu Zhou
YBYaoyao Bian
Yaoyao Bian

1 October 2021 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
LWLiang Wu
Liang Wu
AKAn Kang
An Kang
XJXiaoliang Jin
Xiaoliang Jin
YBYuqing Bao
Yuqing Bao
PMPeng Miao
Peng Miao
ZZZhu Zhou
Zhu Zhou

11 October 2024 in Clinical and Translational Science
Verified
Journal Article
Open access
LWLiang Wu
Liang Wu
LDLinling Dong
Linling Dong
ZZZhu Zhou
Zhu Zhou
XWXin Wang
Xin Wang
YLYujie Lin
Yujie Lin
ZFZhiyi Fang
Zhiyi Fang
Pedunculoside and rotundic acid, the most abundant components in plants of the genus Ilex L. (Aquifoliaceae), exhibit biological and pharmacological significance in the treatment of cardiovascular diseases. However, there have been few studies on their metabolism. This study performed a systematic metabolism study of pedunculoside and rotundic acid and evaluated their potential for herb–drug interaction. Pedunculoside or rotundic acid was incubated with human liver microsomes and recombinant human metabolic enzymes, and analyzed using LC‐Q‐TOF/MS and LC–MS/MS. Pedunculoside was found to be the most stable in human liver microsomes, whereas rotundic acid was easily metabolized. Eight pedunculoside metabolites and six rotundic acid metabolites were detected and tentatively identified through hydroxylation, glucuronidation, acetylation, and glucose conjugation. Hydroxylation of pedunculoside is mainly catalyzed by CYP3A4/5 and partly by CYP2C8. Hydroxylation of rotundic acid is almost exclusively catalyzed by CYP3A4/5, and its glucuronidation reaction is mediated by UGT1A4. Neither pedunculoside nor rotundic acid showed CYP inhibition (IC50 values > 50 μM) with the probe substrates of major CYP isoforms during incubation with human liver microsomes. This study is the first investigation into the in vitro metabolism of pedunculoside and rotundic acid using human liver microsomes. It also aims to assess their potential as perpetrators of drug–drug interactions involving CYP enzymes. The comprehensive metabolism and drug interaction studies of pedunculoside and rotundic acid enable us to evaluate and manage potential risks with their use in pharmacotherapy.